Significance of the Detection of Ki-ras Codon 12 Mutation in the Diagnosis and Differential Diagnosis of Pancreatic Carcinoma

Abstract

Ki-ras codon 12 mutation was detected in: (1) surgically resected formalin-fixed and paraffin-embedded specimens from 109 carcinoma cases, including 46 pancreatic, 35 ampullary, 24 extrahepatic bile duct, and 4 gallbladder carcinomas, showing prevalences of 95.7%, 5.7%, 8.3%, and 0%, respectively, by polymerase chain reaction-restriction fragment length polymorphism technique, and 89.1%, 2.9%, 8.3%, and 0%, respectively, by polymerase chain reaction-dot blot method; and (2) 35 consecutive fine-needle aspiration biopsy specimens by polymerase chain reaction-restriction fragment length polymorphism giving a positive rate of 94.7% (18/19) for pancreatic carcinoma and 0% (0/16) in the specimens from nonpancreatic carcinoma tissues or tumors. Our results demonstrate that the strikingly high prevalence of Ki-ras codon 12 mutation of pancreatic carcinoma could be used as an effective means in the diagnosis and differential diagnosis of pancreatic carcinoma.

Keywords

Ki-ras codon 12 mutation pancreatic carcinoma fine-needle aspiration biopsy polymerase chain reaction-restriction fragment length polymorphism

Get full access to this article

View all access options for this article.

References

Lemoine

Jain

Hughes

Staddon

Maillet

Hall

Kloppel

Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 102:230–236, 1992.

Shibata

Almoguera

Forrester

Dunitz

Martin

Cosgrove

Perucho

Arnheim

Detection of c-Ki-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas. Cancer Res 50:1279–1283, 1990.

Tada

Omata

Ohto

Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 100:233–238, 1991.

Urban

Ricci

Grange

J-D

Lacave

Boudghene

Breittmayer

Languille

Roland

Bernaudin

J-F.

Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst 85:2008–2011, 1993.

Motojima

Tsunoda

Kanematsu

Nagata

Urano

Shika

Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutation in the Kirsten-ras oncogene. Ann Surg 214:657–662, 1991.

Levi

Urbano-Ispizuna

Gill

Thomas

Gilbertson

Foster

Marshall

CJ.

Multiple K-ras codon 12 mutation in cholangiocarcinoma demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 51:3497–3502, 1991.

Hruban

van Mansfeld

ADM

Offerhaus

GJA

van Weering

DHJ

Allison

Goodman

Kensler

Bose

Cameron

Bos

JL.

K-ras oncogene activation in adenocarcinoma of the human pancreas: A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 143:545–554, 1993.

Wang

Zhang

Cui

QC.

Extraction of DNA template from pathological specimens. J Diagn Pathol 1:25–27, 1994 (in Chinese).

Almoguera

Shibata

Forrester

Martin

Arnheim

Perucho

Most human carcinomas of the exocrine pancreas contain mutant c-k-ras genes. Cell 53:549–554, 1988.

10.

Smit

VTHBM

Boot

AJM

Smits

AMM

Fleuren

Cornelisse

Bos

JL.

K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 16:7773–7782, 1988.

11.

Liu

TH.

Oncogene expression and point mutation in human pancreatic adenocarcinomas. Chin J Pathol 21:152–155, 1992 (in Chinese).

12.

Pellegata

Sessa

Renault

Bonato

Leone

Solcia

Ranzani

GN.

K-ras and P⁵³ gene mutations in pancreatic cancer: Ductal and nonductal tumors progress through different genetic lesions. Cancer Res 54:1556–1560, 1994.

13.

Wang

Liu

Chen

Cui

Wang

DT.

Detection of Ki-ras oncogene mutations in normal mucosa, adenoma and adenocarcinoma of the colon. Chin J Pathol 22:333–336, 1993 (in Chinese).

14.

Cui

Wang

Chen

Wang

Liu

TH.

Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreatic tissue. Acta Acad Med Sinicae 16:201–205, 1994 (in Chinese).